AI-generated summary
The authors report a study of a new dual-wavelength laser using 532 nm light with three pulse structures to treat rosacea in 21 enrolled subjects, with up to three monthly treatments. Blinded physician observers correctly identified posttreatment images 89% of the time in 17 of 19 completers, and side effects were limited to short-term erythema and edema.
- Participants
- 21
- Who or what was studied
- Adults with rosacea enrolled in an IRB-approved study; 21 enrolled, 19 completed, 17 analyzed for observer identification
- Wavelengths
- 532, 1064 nm
- Limits stated in the abstract
- The abstract reports a small sample and no control group, and it does not describe a comparator arm to support the claim of effectiveness.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 532 nm, 1064 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Wavelength, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.